ReviewFrontiers in cell and developmental biology2026
Adipose tissue for reconstruction and wound healing: applications, challenges, and future directions.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adipose tissue has emerged as an important therapeutic resource in regenerative medicine due to its accessibility and its rich content of regenerative cells and bioactive factors. Adipose-derived products, including lipoaspirate, stromal vascular fraction (SVF), and adipose-derived mesenchymal stromal/stem cells (AD-MSCs), are increasingly used in clinical practice for tissue reconstruction, wound healing, and the treatment of complex tissue defects. In this review, we summarize current clinical applications of adipose tissue-based therapies, focusing on their role in tissue regeneration and wound management. We briefly discuss adipose tissue harvesting techniques and the biological characteristics of AD-MSCs relevant to their therapeutic use. Attention is given to clinical evidence regarding efficacy, safety, and translational challenges associated with SVF- and AD-MSC-based interventions. We highlight current limitations and future directions for the integration of adipose tissue-derived therapies into regenerative and reconstructive medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.